MPox Vaccinations: A Must-Have for High-Risk Men, Even After the Outbreak Ends

CDC Recommends MPox Vaccine for High-Risk Men

News Picture: CDC Advisors Say High-Risk Men Should Still Get MPox Vaccine

CDC advisors recommend high-risk men receive MPox vaccine.

By Robin Foster and Ernie Mundell and Cara Murez

THURSDAY, Oct. 26, 2023 (HealthDay News) – High-risk men, listen up! Even after the ongoing MPox outbreak subsides, advisors to the U.S. Centers for Disease Control and Prevention (CDC) have strongly recommended that you still roll up your sleeves for that much-needed MPox vaccination. Why? Well, my friend, you fall into that vulnerable group which includes men who have sex with men, people who engage in multiple sexual partnerships, individuals who have recently battled sexually transmitted diseases, and those who are at higher risk for various infections via sexual contact.

Now, I know what you’re thinking, “Is the CDC just pulling my leg?” But hold on, folks, this is serious business. The MPox virus, formerly known as monkeypox, belongs to the same virus family as smallpox and runs rampant in certain parts of Africa. Trust me, you don’t want to ignore this advice.

It’s important to note that CDC Director Mandy Cohen still needs to give her official stamp of approval, but hey, it’s looking promising! This recommendation came during a meeting of the CDC’s Advisory Committee on Immunization Practices.

Now, let’s talk numbers. In 2023, the number of MPox cases in the United States has tapered to a mere 800, compared to a staggering 30,000 cases just last year. That’s quite the drop, right? But don’t start celebrating just yet. In 2022, MPox wreaked havoc among men who have sex with men in Europe and the United States, leading to widespread concern.

In the present day, the average daily count of new cases ranges from one to four. While it’s true that only two deaths were reported in September, the Associated Press has reported a total of 54 fatalities resulting from MPox outbreaks in the U.S. And believe me, these outbreaks aren’t pretty – many unfortunate souls endured weeks of excruciatingly painful lesions.

But hey, there’s a glimmer of hope in San Francisco! Last year, the city suffered over 800 MPox cases, but now the numbers have dropped significantly, albeit with some variation. For example, in August there were only seven cases reported, but September saw a surge with 20 cases, and this month has already racked up at least 10 known cases. Progress, my friends, progress!

To contain the spread of MPox, health authorities have been distributing the two-dose Jynneos vaccine to more than 500,000 people across the United States. However, there’s still work to be done as approximately 2 million people remain eligible for the shot, according to the CDC. Come on, folks, let’s get those arms ready!

Dr. Stephanie Cohen, medical director of the San Francisco City Clinic and an assistant professor in the division of infectious diseases at the University of California, San Francisco, acknowledges that things have improved since last summer. However, she emphasizes that there are still more cases than there should be. So, high-risk men, don’t drop the ball just yet – stay vigilant!

For more information, visit the World Health Organization website.

SOURCES: Associated Press